pramipexole has been researched along with vinorelbine in 1 studies
| Studies (pramipexole) | Trials (pramipexole) | Recent Studies (post-2010) (pramipexole) | Studies (vinorelbine) | Trials (vinorelbine) | Recent Studies (post-2010) (vinorelbine) |
|---|---|---|---|---|---|
| 1,103 | 219 | 517 | 50 | 0 | 31 |
| Protein | Taxonomy | pramipexole (IC50) | vinorelbine (IC50) |
|---|---|---|---|
| Tubulin beta-4A chain | Homo sapiens (human) | 1.35 | |
| Cholinesterase | Homo sapiens (human) | 0.7 | |
| Tubulin beta chain | Homo sapiens (human) | 1.35 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 1 | |
| Tubulin alpha-3C chain | Homo sapiens (human) | 1.35 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.7 | |
| Substance-K receptor | Homo sapiens (human) | 1.6062 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.7 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.7 | |
| Tubulin alpha-1B chain | Homo sapiens (human) | 1.35 | |
| Tubulin alpha-4A chain | Homo sapiens (human) | 1.35 | |
| Tubulin beta-4B chain | Homo sapiens (human) | 1.35 | |
| Tubulin beta-3 chain | Homo sapiens (human) | 1.35 | |
| Tubulin beta-2A chain | Homo sapiens (human) | 1.35 | |
| Tubulin beta-8 chain | Homo sapiens (human) | 1.35 | |
| Tubulin alpha-3E chain | Homo sapiens (human) | 1.35 | |
| Tubulin alpha-1A chain | Homo sapiens (human) | 1.35 | |
| Tubulin alpha-1C chain | Homo sapiens (human) | 1.35 | |
| Tubulin beta-6 chain | Homo sapiens (human) | 1.35 | |
| Tubulin beta-2B chain | Homo sapiens (human) | 1.35 | |
| Tubulin beta-1 chain | Homo sapiens (human) | 1.35 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for pramipexole and vinorelbine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |